Fred Hassan Joins Bausch & Lomb Board of Directors
FOR IMMEDIATE RELEASE THURSDAY, NOVEMBER 12, 2009
ROCHESTER, N.Y. -- Bausch & Lomb, the global eye health company, today announced that Fred Hassan has been elected to its Board of Directors.
Mr. Hassan was chairman and CEO of Schering-Plough Corporation from 2003 until its acquisition by Merck & Co., Inc., on November 3. Before joining Schering-Plough, he served as CEO (from 2000 to 2001) and as chairman and CEO (from 2001 to 2003) of Pharmacia Corporation until the company was acquired by Pfizer Inc. in 2003. From 1997 to 2000, Mr. Hassan was CEO of Pharmacia & Upjohn, Inc., which merged with Monsanto Company in 2000 to become Pharmacia Corporation. From 1972 to 1997, he served in various senior management roles at major pharmaceutical companies.
“Bausch & Lomb and its customers will benefit from Fred Hassan’s extensive global business experience and his in-depth knowledge of the healthcare industry,” said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb. “We will especially value Fred's insights as we develop and market innovative pharmaceutical products for the global eye health industry."
Mr. Hassan is the past chairman of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) and is the past chairman of the HealthCare Institute of New Jersey. He is also the immediate past president of the International Federation of Pharmaceutical Manufacturers Associations. In addition, he is a member of the Board of Directors of Time Warner Inc. and the Lead Director on the Board of Directors of Avon Products, Inc. He holds a bachelor’s of science degree from the Imperial College of Science and Technology at the University of London and an M.B.A. degree from Harvard Business School.
Mr. Hassan joins board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman, retired CFO, Honeywell International, Inc.; R. Kerry Clark, retired CEO, Cardinal Health; Bob Palmisano, president, CEO and director, ev3 Inc.; and Gerald M. Ostrov.
About Bausch & Lomb
Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.